China Pharma Holdings, Inc.
CPHI- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106644
No open-market purchases or sales by China Pharma Holdings, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $134.5K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding China Pharma Holdings, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 5 | 7 | +2 |
| Shares | 305.5K | 611.9K | +306.4K (+100.3%) |
| Value | $45.4K | $73.8K | +$28.5K (+62.8%) |
New holders (4)
Institutions that held China Pharma Holdings, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 166,213 | $20.1K | 0.00% |
| JPMorgan Chase & Co | 65,422 | $7.92K | 0.00% |
| UBS Group AG | 34,300 | $4.15K | 0.00% |
| HRT Financial LP | 21,039 | $2.00K | 0.00% |
Sold out (2)
Institutions that held China Pharma Holdings, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Two Sigma Securities, LLC | 60,844 | $9.01K |
| Renaissance Technologies LLC | 30,930 | $5.00K |